TSPI, LP
TSPI, LP is a venture-capital, growth-equity and buyout fund in the US, Europe and Asia investing in Healthcare and technology.
- Stages
- venture-capital, growth-equity, buyout
- Sectors
- Healthcare, technology
- Invests in
- US-wide, Europe, Asia
- Round role
- Leads rounds
Check size not disclosed
Thesis
TSPI, LP, formerly Sightway Capital, LP, is a Delaware limited partnership established in January 2018 and renamed in August 2020. The firm manages two fund families: the Sightway Funds, which focus on long-term, discretionary strategies and building platform companies in asset-intensive industries through predominantly non-public investments (public investments also permitted), and the TSPI Fund, which targets U.S. dollar-denominated returns through diversified private investments across private equity, credit, special opportunities, real assets, infrastructure, real estate, and venture capital. TSPI actively co-invests alongside external General Partners (GPs) and also leads direct deals. Their unique differentiator is the integration of quantitative rigor and systematic data analysis into private market investing. Geographically, TSPI focuses on North America and considers select opportunities in Europe and Asia. The firm targets a broad stage spectrum, from venture capital to growth equity and buyout opportunities, applying its systematic approach across company lifecycles. Investments are typically concentrated in technology, healthcare, and other data-rich sectors where machine learning can add value. As of December 31, 2025, TSPI, LP reported regulatory Assets Under Management (AUM) of $1,924,326,813, with another source indicating a total AUM of $2.1 billion as of June 2, 2025. The AUM is predominantly allocated to pooled investment vehicles.
Common questions
Does TSPI, LP invest at the venture-capital stage?
Yes. TSPI, LP lists venture-capital, growth-equity and buyout among the stages it invests in.
Where does TSPI, LP invest?
TSPI, LP invests in the US, Europe and Asia.